Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures: A Randomized Controlled Trial

NCT02897856 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT02897856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02897856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures: A Randomized Controlled Trial
Lead sponsor
Hamad Medical Corporation
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2016
Completion date
November 30, 2018
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seizures